Clinical Trials Directory

Trials / Unknown

UnknownNCT04570072

Effect of Probiotic on Comorbidity of Depression and Constipation

Effect of Probiotic on Chinese Patients With Depression and Constipated Comorbidity

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
China Agricultural University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Depressive disorder, also known as depression, is a type of mood disorder characterized by persistent low mood. The incidence of depression worldwide is about 6%. The high comorbidity rate between depression and constipation indicated the role of the gut-brain axis in depression. Growing evidence suggested that the gut microbiota plays a key role in the development of depression. Probiotics can effectively improve constipation and regulate gut microbiota, and showed potential in alleviating depression. This study investigated the effect of formula probiotic (containing Lactobacillus paracasei, Bifidobacterium animals, Bifidobacterium longum, Bifidobacterium bifidum, and Lactobacillus plantarum) on the comorbidity of depression and constipation.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbioticPatients receive the formula probiotic for consecutive 8 weeks ( one sachet per day ).
DIETARY_SUPPLEMENTPlaceboPatients receive the placebo identical to probiotic for consecutive 8 weeks ( one sachet per day ).

Timeline

Start date
2020-11-01
Primary completion
2021-06-30
Completion
2021-12-30
First posted
2020-09-30
Last updated
2020-09-30

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04570072. Inclusion in this directory is not an endorsement.